Greenwood Capital Associates LLC Johnson & Johnson Transaction History

Greenwood Capital Associates LLC

$755 Million
Q3 2024

A detailed history of Greenwood Capital Associates LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Greenwood Capital Associates LLC holds 71,927 shares of JNJ stock, worth $11.1 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares

71,927

Previous 66,069 8.87%

Holding current value

$11.1 Million

Previous $9.66 Million 20.71%

% of portfolio

1.54%

Previous 1.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$145.48 - $167.38 $852,221 - $980,512	5,858 Added 8.87%	71,927 $11.7 Million
Q2 2024 Aug 08, 2024	SELL	$144.38 - $157.78 $97,312 - $106,343	-674 Reduced 1.01%	66,069 $9.66 Million
Q1 2024 May 01, 2024	SELL	$155.22 - $162.74 $2.96 Million - $3.1 Million	-19,071 Reduced 22.22%	66,743 $10.6 Million
Q4 2023 Mar 05, 2024	SELL	$145.6 - $158.88 $39,312 - $42,897	-270 Reduced 0.31%	85,814 $13.5 Million
Q3 2023 Oct 18, 2023	SELL	$155.75 - $174.48 $616,302 - $690,417	-3,957 Reduced 4.39%	86,084 $13.4 Million
Q2 2023 Aug 07, 2023	BUY	$154.35 - $166.11 $323,517 - $348,166	2,096 Added 2.38%	90,041 $14.9 Million
Q1 2023 May 12, 2023	BUY	$151.05 - $180.26 $138,512 - $165,298	917 Added 1.05%	87,945 $13.6 Million
Q4 2022 Jan 26, 2023	SELL	$160.2 - $179.79 $641,440 - $719,879	-4,004 Reduced 4.4%	87,028 $0
Q3 2022 Nov 10, 2022	SELL	$161.33 - $179.52 $1.75 Million - $1.95 Million	-10,861 Reduced 10.66%	91,032 $14.9 Million
Q2 2022 Aug 10, 2022	BUY	$168.19 - $186.01 $17 Million - $18.8 Million	101,074 Added 12341.15%	101,893 $18.1 Million
Q1 2022 May 10, 2022	SELL	$158.14 - $179.59 $12.7 Million - $14.4 Million	-80,185 Reduced 98.99%	819 $145,000
Q4 2021 Feb 03, 2022	BUY	$155.93 - $173.01 $231,088 - $256,400	1,482 Added 1.86%	81,004 $13.9 Million
Q3 2021 Oct 27, 2021	BUY	$161.5 - $179.47 $53,941 - $59,942	334 Added 0.42%	79,522 $12.8 Million
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $266,012 - $285,344	-1,668 Reduced 2.06%	79,188 $13 Million
Q1 2021 May 14, 2021	SELL	$153.07 - $170.48 $891,632 - $993,045	-5,825 Reduced 6.72%	80,856 $13.3 Million
Q4 2020 Feb 09, 2021	BUY	$137.11 - $157.38 $585,185 - $671,697	4,268 Added 5.18%	86,681 $13.6 Million
Q3 2020 Nov 12, 2020	BUY	$140.38 - $153.83 $725,343 - $794,839	5,167 Added 6.69%	82,413 $12.3 Million
Q2 2020 Aug 12, 2020	SELL	$128.81 - $155.51 $1.45 Million - $1.75 Million	-11,271 Reduced 12.73%	77,246 $10.9 Million
Q1 2020 May 12, 2020	SELL	$111.14 - $153.99 $82,799 - $114,722	-745 Reduced 0.83%	88,517 $11.6 Million
Q4 2019 Feb 12, 2020	BUY	$127.5 - $146.44 $516,502 - $593,228	4,051 Added 4.75%	89,262 $13 Million
Q3 2019 Nov 12, 2019	BUY	$126.95 - $142.14 $943,746 - $1.06 Million	7,434 Added 9.56%	85,211 $11 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $160,591 - $179,807	-1,265 Reduced 1.6%	77,777 $10.8 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $122,887 - $135,152	937 Added 1.2%	79,042 $11 Million
Q1 2019 May 03, 2019	BUY	$125.72 - $139.79 $62,357 - $69,335	496 Added 0.64%	78,105 $10.9 Million
Q4 2018 Feb 11, 2019	BUY	$122.84 - $147.84 $1.82 Million - $2.19 Million	14,841 Added 23.64%	77,609 $10 Million
Q3 2018 Nov 13, 2018	SELL	$121.58 - $142.88 $29,179 - $34,291	-240 Reduced 0.38%	62,768 $8.67 Million
Q2 2018 Aug 07, 2018	BUY	$119.4 - $131.76 $346,260 - $382,104	2,900 Added 4.82%	63,008 $7.65 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $602,982 - $714,034	4,820 Added 8.72%	60,108 $7.7 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $82,537 - $90,336	-629 Reduced 1.12%	55,288 $7.73 Million
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $7.24 Million - $7.57 Million	55,917	55,917 $7.27 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $405B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Account

Greenwood Capital Associates LLC Johnson & Johnson Transaction History